180 Episodo

  1. PARP Inhibitors in the Management of Ovarian Cancer Rapid Recommendation Update

    Publicado: 3/10/2022

  2. Secondary Prevention of Cervical Cancer Resource-Stratified Guideline Update

    Publicado: 26/9/2022

  3. Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation Update

    Publicado: 21/9/2022

  4. Integrative Medicine for Pain Management in Oncology: SIO-ASCO Guideline

    Publicado: 19/9/2022

  5. Chemotherapy and Targeted Therapy for HER2-Negative Metastatic Breast Cancer that is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Rapid Recommendation Update

    Publicado: 4/8/2022

  6. Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations: ASCO Living Guideline (Part 1)

    Publicado: 11/7/2022

  7. Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations: ASCO Living Guideline (Part 2)

    Publicado: 11/7/2022

  8. Biomarkers for Systemic Therapy in Metastatic Breast Cancer Guideline Update

    Publicado: 27/6/2022

  9. Management of Metastatic Clear Cell Renal Cell Carcinoma Guideline

    Publicado: 21/6/2022

  10. Systemic Therapy for Melanoma Rapid Recommendation Update

    Publicado: 3/6/2022

  11. Management of Advanced HER2-Positive Breast Cancer and Brain Metastases Guideline Update

    Publicado: 31/5/2022

  12. Systemic Therapy for Advanced HER2-Positive Breast Cancer Guideline Update

    Publicado: 31/5/2022

  13. Exercise, Diet, and Weight Management During Cancer Treatment Guideline

    Publicado: 16/5/2022

  14. Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline

    Publicado: 13/5/2022

  15. Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer Guideline Update

    Publicado: 19/4/2022

  16. Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-risk, Early-stage Triple Negative Breast Cancer Rapid Recommendation Update

    Publicado: 13/4/2022

  17. Management and Care of Patients with Invasive Cervical Cancer: Resource-Stratified Guideline Rapid Recommendation Update

    Publicado: 7/3/2022

  18. Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update

    Publicado: 24/2/2022

  19. Somatic Genomic Testing in Patients with Metastatic or Advanced Cancer Provisional Clinical Opinion

    Publicado: 17/2/2022

  20. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected NSCLC Guideline Rapid Recommendation Update

    Publicado: 14/2/2022

4 / 9

Explore pivotal recommendations from the latest evidence-based clinical practice guidance with ASCO Guidelines. Join us to discover essential insights and navigate the ever-evolving landscape of cancer research and treatment.

Visit the podcast's native language site